BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21558437)

  • 1. Anxiolytic-like activity of pregabalin in the Vogel conflict test in α2δ-1 (R217A) and α2δ-2 (R279A) mouse mutants.
    Lotarski SM; Donevan S; El-Kattan A; Osgood S; Poe J; Taylor CP; Offord J
    J Pharmacol Exp Ther; 2011 Aug; 338(2):615-21. PubMed ID: 21558437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticonvulsant activity of pregabalin in the maximal electroshock-induced seizure assay in α2δ1 (R217A) and α2δ2 (R279A) mouse mutants.
    Lotarski S; Hain H; Peterson J; Galvin S; Strenkowski B; Donevan S; Offord J
    Epilepsy Res; 2014 Jul; 108(5):833-42. PubMed ID: 24698052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel alpha2-delta type 1 subunit is the major binding protein for pregabalin in neocortex, hippocampus, amygdala, and spinal cord: an ex vivo autoradiographic study in alpha2-delta type 1 genetically modified mice.
    Bian F; Li Z; Offord J; Davis MD; McCormick J; Taylor CP; Walker LC
    Brain Res; 2006 Feb; 1075(1):68-80. PubMed ID: 16460711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregabalin action at a model synapse: binding to presynaptic calcium channel alpha2-delta subunit reduces neurotransmission in mice.
    Joshi I; Taylor CP
    Eur J Pharmacol; 2006 Dec; 553(1-3):82-8. PubMed ID: 17064682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pregabalin may represent a novel class of anxiolytic agents with a broad spectrum of activity.
    Field MJ; Oles RJ; Singh L
    Br J Pharmacol; 2001 Jan; 132(1):1-4. PubMed ID: 11156553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery.
    Taylor CP; Angelotti T; Fauman E
    Epilepsy Res; 2007 Feb; 73(2):137-50. PubMed ID: 17126531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amperometric measurement of glutamate release modulation by gabapentin and pregabalin in rat neocortical slices: role of voltage-sensitive Ca2+ α2δ-1 subunit.
    Quintero JE; Dooley DJ; Pomerleau F; Huettl P; Gerhardt GA
    J Pharmacol Exp Ther; 2011 Jul; 338(1):240-5. PubMed ID: 21464332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of pregabalin and analogues that target the alpha(2)-delta protein.
    Belliotti TR; Capiris T; Ekhato IV; Kinsora JJ; Field MJ; Heffner TG; Meltzer LT; Schwarz JB; Taylor CP; Thorpe AJ; Vartanian MG; Wise LD; Zhi-Su T; Weber ML; Wustrow DJ
    J Med Chem; 2005 Apr; 48(7):2294-307. PubMed ID: 15801823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating the mechanism of action of pregabalin: α(2)δ as a therapeutic target in anxiety.
    Micó JA; Prieto R
    CNS Drugs; 2012 Aug; 26(8):637-48. PubMed ID: 22784017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin.
    Field MJ; Cox PJ; Stott E; Melrose H; Offord J; Su TZ; Bramwell S; Corradini L; England S; Winks J; Kinloch RA; Hendrich J; Dolphin AC; Webb T; Williams D
    Proc Natl Acad Sci U S A; 2006 Nov; 103(46):17537-42. PubMed ID: 17088553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregabalin: From molecule to medicine.
    Kavoussi R
    Eur Neuropsychopharmacol; 2006 Jul; 16 Suppl 2():S128-33. PubMed ID: 16765030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity profile of pregabalin in rodent models of epilepsy and ataxia.
    Vartanian MG; Radulovic LL; Kinsora JJ; Serpa KA; Vergnes M; Bertram E; Taylor CP
    Epilepsy Res; 2006 Mar; 68(3):189-205. PubMed ID: 16337109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunits.
    Li Z; Taylor CP; Weber M; Piechan J; Prior F; Bian F; Cui M; Hoffman D; Donevan S
    Eur J Pharmacol; 2011 Sep; 667(1-3):80-90. PubMed ID: 21651903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural requirement of the calcium-channel subunit alpha2delta for gabapentin binding.
    Wang M; Offord J; Oxender DL; Su TZ
    Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):313-20. PubMed ID: 10455017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The alpha2-delta protein: an auxiliary subunit of voltage-dependent calcium channels as a recognized drug target.
    Thorpe AJ; Offord J
    Curr Opin Investig Drugs; 2010 Jul; 11(7):761-70. PubMed ID: 20571971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative splicing of the Ca2+ channel beta4 subunit confers specificity for gabapentin inhibition of Cav2.1 trafficking.
    Mich PM; Horne WA
    Mol Pharmacol; 2008 Sep; 74(3):904-12. PubMed ID: 18583457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pregabalin: new therapeutic contributions of calcium channel alpha2delta protein ligands on epilepsy and neuropathic pain].
    Horga de la Parte JF; Horga A
    Rev Neurol; 2006 Feb 16-28; 42(4):223-37. PubMed ID: 16521062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregabalin: a new anxiolytic.
    Lauria-Horner BA; Pohl RB
    Expert Opin Investig Drugs; 2003 Apr; 12(4):663-72. PubMed ID: 12665421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin pharmacology and its relevance to clinical practice.
    Ben-Menachem E
    Epilepsia; 2004; 45 Suppl 6():13-8. PubMed ID: 15315511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.